Once-daily timolol formulation OK'd

The FDA has approved a new drug application by ISTA Pharmaceuticals for the once-daily liquid formulation of timolol 0.5% as a therapy for glaucoma.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.